Background. Few studies have examined the risk factors for and timing of venous thromboembolism (VTE) in patients undergoing surgical procedures for lung cancer, and there are limited data to formulate guidelines for extended VTE prophylaxis after hospital discharge. This study sought to identify risk factors for postdischarge VTE after lung resection.
Methods. Patients undergoing anatomic resection for lung cancer were identified in the National Surgical Quality Improvement Program database from 2005 to 2015. Patients' demographic and clinical characteristics were evaluated for any association with postdischarge VTE. Predictors of postdischarge VTE were identified using multivariable analysis.
Results. VTE occurred in 1.6% (234) of the 14,308 patients identified; 44% (102) VTE events occurred after hospital discharge. Undergoing pneumonectomy was associated with a threefold increased risk for postdischarge VTE compared with lobectomy (2.0% versus 0.6%, p < 0.01), as was open resection compared with minimally invasive resection (0.8% versus 0.6%, p < 0.01). Prolonged operative time (>75th percentile) was also associated with an increased risk for postdischarge VTE compared with shorter operative time. Multivariable analysis identified older age, obesity, pneumonectomy, and prolonged operative time as independent predictors of postdischarge VTE.
Conclusions. Significant proportions of VTE events occur after hospital discharge. Although there are data to suggest that the risk for VTE extends beyond this period, few patients are managed with postdischarge prophylaxis. These data suggest that postdischarge prophylaxis should be considered for those patients at high risk for VTE, particularly for older patients, those who are obese, and after extended or lengthy resections.
(Ann Thorac Surg 2018;105:1469-75) Ó 2018 by The Society of Thoracic Surgeons V enous thromboembolism (VTE), consisting of both deep vein thrombosis (DVT) and pulmonary embolism (PE), is a well-documented cause of morbidity and mortality in the surgical population [1] [2] [3] . Patients with lung cancer who are undergoing resection have a higher risk of VTE compared with patients with other solid organ malignant tumors [2, [4] [5] [6] . The cause of VTE in patients with lung cancer is likely the result of patient-related risk factors such as age, obesity, smoking, and race, as well as cancer-related factors including tumor biology, histologic features, and stage of disease [7] [8] [9] . Patients with lung cancer are also at increased risk for perioperative VTE because of extended periods of bed rest, reduced postoperative ambulation, and higher levels of discomfort associated with chest incisions. Additional treatmentrelated risk factors, including performance of thoracotomy and extent of resection, have been associated with risk for VTE in earlier studies [8, 10] .
A wide range of VTE rates after lung resection has been reported (0.2% to 20%), likely resulting from varying compliance with chemical and mechanical VTE prophylaxis [11] [12] [13] [14] . A recent systematic review, including more than 10,000 patients undergoing lung operations, found that the majority of VTE cases occurred in the initial postoperative period, with an incident risk lasting up to 30 days after resection [12, 15] . Although the in-hospital postoperative period is recognized as a critical interval for the development of VTE, this risk persists after hospital discharge [16, 17] .
Indeed, the burden of postdischarge VTE has been documented in subsets of patients undergoing resection for abdominal and pelvic malignant diseases, in which the use of extended VTE prophylaxis is founded on strong evidence [6, [18] [19] [20] [21] . However, few studies have examined the association of these risk factors and the development of VTE in thoracic surgical patients. Furthermore, there are limited data from which to formulate recommendations on the timing and duration of VTE prophylaxis, thus leading to a lack of clear guidelines that define optimal prophylaxis use in this patient population. Therefore, the objectives of this study were to (1) describe the frequency of overall and postdischarge VTE after lung cancer operations and (2) identify patients at high risk for postdischarge VTE. These objectives serve to establish a foundation that may help guide the use of extended VTE prophylaxis after hospital discharge.
Patients and Methods

Data Sources
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) and participating hospitals are the sources of the data used herein; they have not verified and are not responsible for the statistical validity of our data analysis or our conclusions. Patients were selected from the ACS NSQIP participant use data file from 2005 to 2015. The participant use data file contains Health Information Portability and Accountability Act-compliant, deidentified information. This study was granted exemption from the Yale University School of Medicine Institutional Review Board.
Study Population
Patients 18 years of age or older, who were treated between 2005 and 2015, and who underwent anatomic lung resection were included. Both open operative and video-assisted thoracoscopic surgery (VATS) approaches were considered. The index operation was identified on the basis of current procedural terminology codes (Appendix). Patients were included if they underwent lung resection for cancer, identified by the appropriate International Classification of Diseases-Ninth Revision or (ICD-9) or Tenth Revision (ICD-10) diagnosis code. Emergency cases were excluded.
Data Elements
Patients' demographic and preoperative risk factors assessed included age, sex, race, body mass index, American Society of Anesthesiologists physical status classification (ASA class), loss of >10% of body weight in the 6 months before operation, hypertension, diabetes, and the presence of disseminated cancer at the time of operation (not including locally advanced or nodal disease). Pulmonary-specific variables included a previous history of chronic obstruction pulmonary disease, dyspnea, and smoking status (current: active smoking or within 1 year of the operation versus former). Perioperative variables were evaluated, including surgical approach (VATS versus open), extent of resection (lobectomy or bilobectomy versus pneumonectomy), and extended operating time, defined as an operative time greater than or equal to the 75th percentile of the study population. Extended hospital length of stay was defined as a length of stay greater than the 75th percentile of the study population. The occurrence of other ACS NSQIPdefined postoperative and predischarge complications was also evaluated for any association with overall and postdischarge VTE.
Outcomes
The main outcomes of the study were the overall and postdischarge occurrences of VTE within 30 days of operation, a composite variable created by the occurrence of either postoperative DVT or postoperative PE. If a patient had both DVT and PE, the VTE that occurred first was recorded. The criterion for postoperative PE, as defined by the ACS NSQIP, is a pulmonary embolism identified within 30 days after the principal operative procedure and both of the following: (1) a new diagnosis of a blood clot in a pulmonary artery; and (2) a ventilation-perfusion scan interpreted as indicating a high probability of pulmonary embolism or a positive result on a computed tomography examination, transesophageal echocardiogram, pulmonary arteriogram, computed tomography angiogram, or any other definitive imaging modality, including direct pathology examination such as autopsy. The ACS NSQIP definition of a DVT is a blood clot or thrombus within a deep vein of either the arm or leg that is identified within 30 days after the principal operative procedure including both of the following: (1) a new diagnosis of a deep venous thrombosis, confirmed by a duplex, venogram, computed tomography scan, or any other definitive imaging modality, including direct pathology examination such as autopsy; and (2) the need for treatment with anticoagulation therapy or placement of a vena cava filter or clipping of the vena cava or an indication on the patient's record that treatment was warranted but there was no additional appropriate treatment option available. Thirty-day mortality and readmission after lung resection were compared among patients who sustained predischarge and postdischarge VTE. This analysis excluded patients who remained in the hospital at 30 days from their index operation and those who died within 30 days of resection because neither group was at risk for readmission.
Statistical Analysis
Bivariate analysis included the association of predischarge and postdischarge VTE with each of the demographic and perioperative risk factors, as well as any association with the occurrence of additional postoperative complications using the c 2 test. To identify demographic and perioperative predictors of postdischarge VTE, multivariable analysis was performed using logistic regression modeling, including a backward elimination technique. A threshold value of p < 0.10 from the bivariate analysis was used for inclusion in the final model. All analyses were performed using SAS software version 9.4 (SAS Institute, Cary, NC).
Results
A total of 14,308 patients who underwent lobectomy, bilobectomy, or pneumonectomy for lung cancer were identified. The frequency of VTE was 1.6% in the study group, with DVT being the most common subtype, identified in 1.1% (150) of patients; 32 patients sustained both DVT and PE during the study period ( Table 1) .
The median time to diagnosis of DVT was similar to that of PE. Figure 1 demonstrates the occurrence of DVT and PE in relation to hospital discharge; 44% (102) VTE events occurred after hospital discharge. Of the 116 PEs that occurred, 58% (67) of events took place after discharge. Mortality within 30 days of resection was 1.8% in the study population. Sustaining a predischarge or postdischarge VTE was associated with a significantly higher risk of death compared with no VTE (13.6% and 12.8% versus 1.6%; p < 0.05). Table 2 shows the demographic and perioperative characteristics of the study population stratified by the occurrence of predischarge or postdischarge VTE. Patients older than 65 years were more likely to sustain a postdischarge VTE compared with younger patients (0.9% versus 0.4%; p < 0.01). Men were more likely to sustain a postdischarge VTE compared with women (0.9% versus 0.6%; p < 0.01). Patients with an ASA classification of 4 had twice the frequency of postdischarge VTE compared with patients who were ASA 1 or 2 and ASA 3 (1.4% versus 0.6% and 0.7%, respectively; p < 0.05). A history of severe chronic obstruction pulmonary disease was also associated with an increased risk for postdischarge VTE (0.9% versus 0.6%; p < 0.01).
Undergoing pneumonectomy was associated with a threefold increase in postdischarge VTE compared with lobectomy (2.0% versus 0.6%; p < 0.01), as was open resection compared with minimally invasive resection (0.8% versus 0.6%; p < 0.01). Prolonged duration of an operation (1.0% versus 0.6%; p < 0.01) and extended length of stay (0.9% versus 0.6%; p < 0.01) were also associated with an increased risk for postdischarge VTE. Sustaining a predischarge complication was associated with an increased risk for postdischarge VTE (1.1% versus 0.7%; p < 0.01).
Patients with a predischarge VTE were significantly more likely to be readmitted compared with those who did not have a VTE (18.4% versus 7.9%; p < 0.05; Fig 2) . Additionally, patients who sustained a postdischarge VTE had a fourfold increased risk for readmission compared with those who sustained a predischarge VTE (74.6% versus 18.4%; p < 0.05).
Multivariate analysis identified the patient-specific factors of age 65 years and obesity to be independently predictive of postdischarge VTE (p 0.01; Table 3 ). Undergoing pneumonectomy and prolonged duration of an operation were operation-specific factors that also independently predicted postdischarge VTE after controlling for perioperative characteristics (p 0.05).
Comment
This study demonstrated that the risk of VTE after lung resection remains a clinically relevant issue, particularly for patients undergoing resection for cancer. To date, inhospital VTE prophylaxis, including pharmacologic treatment and mechanical prevention (early ambulation and pneumatic compression devices) has been a major focus of evidence-based guidelines. The American College of Chest Physician (CHEST) evidence-based clinical practice guidelines consider patients undergoing thoracic operations to be at a moderate risk for postoperative VTE, and these guidelines recommend either low-dose unfractionated heparin or low-molecularweight heparin during the postoperative period (grade 1B evidence) [20] . However, these guidelines do not address the duration of prophylaxis or provide guidance on the use of extended prophylaxis beyond hospital discharge. Extended prophylaxis guidelines do exist for subsets of patients undergoing abdominal and pelvic surgical procedures and may serve as a model for thoracic patients [21, 22] . However, to date there have been lack of consensus and limited data on the use of extended VTE prophylaxis after lung resection [20, 23] .
In our evaluation, a large proportion of VTE events (44%) occurred after hospital discharge. Although the prevalence of VTE in this study was relatively low (1.6%), 58% of clinically significant PEs that required treatment occurred after discharge. Likely this number underestimates the true prevalence of postdischarge VTE, given that VTE-related readmissions may not have been captured by the ACS NSQIP database. Regardless, it is reasonable to conclude that the risk for postdischarge VTE is clinically significant, and measures to identify high-risk patients should prompt consideration for extended prophylaxis.
The increased risk of VTE after lung resection is clearly multifactorial. We identified several patient-specific risk factors including older age and obesity as independent predictors of postdischarge VTE, consistent with other single-institution series [1, 6, 24] . Previous data have also established the causal relationship between performance of pneumonectomy and risk for VTE [16, 25, 26] . These conclusions are consistent with our analysis; however this manuscript is the first to identify the association between pneumonectomy and VTE risk in the postdischarge period, based on our review of the current literature. Extended operative time was also identified as an independent risk factor for postdischarge VTE, and it should be considered a trigger for extended prophylaxis. We concurrently identified a significant increase in readmission risk for patients who sustained postoperative VTE, as well as a sixfold increased risk of mortality. Given that VTE is a major driver of 30-day mortality after cancer operations, we believe that the use of extended prophylaxis for select patients may have a significant impact on these important outcome metrics.
This current study is one of the largest, to our knowledge, to examine the VTE risk of patients undergoing lung resection. In this study, 45% of resections were minimally invasive (VATS), a finding that reflects national adoption rates over the last decade [27] . Therefore, it is not surprising that our results identified a relative decrease in risk for VTE after VATS resection. However, surgical approach was not an independent predictor of postdischarge VTE in our multivariate analysis. This may reflect the fact that open resection, on average, is associated with prolonged hospital length of stay and likely prolonged inpatient treatment with VTE prophylaxis.
To date, risk assessment tools, including the Caprini VTE risk model, have demonstrated success in identifying patients at risk for postdischarge VTE [28, 29] . Our data corroborate several risk factors used in the Caprini model, including older age, obesity, and extended operative duration [29] . Although this model is not specific to patients with lung cancer and does not include all prognostic factors identified in this analysis (eg, extent of resection or surgical approach), it does support the conclusions derived from our large nationally representative patient sample. Unfortunately, the Caprini risk model could not be applied to our study population because this model assesses risk factors that are unavailable in the ACS NSQIP, including a personal or family history of VTE, ongoing use of anticoagulation or antiplatelet therapy before the surgical procedure, the presence of an inferior vena cava filter, or a history of cerebrovascular accident.
A study of VTE after lung resection in the ACS NSQIP database has several limitations. Foremost is the inability to determine the use, method, and duration of postoperative VTE prophylaxis. However, hospitals participating in the ACS NSQIP are more likely to have high Surgical Care Improvement Project compliance rates and therefore may be more likely to adhere to established CHEST guidelines for postoperative VTE prophylaxis [6] . The lack of data on the use of extended prophylaxis remains a limiting factor, although it is reasonable to presume that few patients received postdischarge prophylaxis, with the exception of patients with an indication for anticoagulation (eg, persistent atrial fibrillation). Indeed, a recent study by Agzarian et al. [23] demonstrated that only 4.6% of physicians use extended VTE prophylaxis after thoracic operations. Additionally, the ACS NSQIP captures only VTE events within 30 days of the index operation and may miss VTE cases that occur in an outside hospital or in patients presenting to an outside hospital; therefore, it may underestimate the true incidence of VTE. However, previous work has demonstrated that the highest incidence of VTE is within this 30-day postoperative window [12, 15] . As a result, we believe that our data are representative of the prevalence of VTE in thoracic surgical patients and provide an appropriate foundation from which guidelines may be revised. The ICD-9 and ICD-10 diagnosis codes used to identify patients are not histologically or cancer stage specific, and therefore this study is unable to account for the impact of stage on VTE risk [30] . Finally, the impact of known perioperative risk factors in thoracic surgical patients, such as pulmonary function test results, long-term smoking history, and preoperative performance status, is not available in the ACS NSQIP dataset.
Despite these limitations, the results of this study demonstrate that significant proportions of VTE events occur after hospital discharge. Although there are sound data to suggest that the risk for VTE extends beyond this period, few patients are managed with postdischarge prophylaxis. The effectiveness of in-hospital VTE prophylaxis has been well established. This study suggests that postdischarge prophylaxis should be considered in patients at high risk for VTE, particularly older and obese patients and patients who undergo extensive or lengthy resections.
